{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:55:48Z","timestamp":1760057748805,"version":"build-2065373602"},"reference-count":97,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Locoregional therapies (LRTs), including transarterial embolization (TAE), transarterial chemoembolization (TACE), and transarterial radioembolization (TARE), have become integral in the management of hepatocellular carcinoma (HCC) in recent decades and continue to shape evolving treatment strategies. While their role in liver tumor management is well established, their potential for treating extrahepatic malignancies is gaining increasing attention. Notably, growing research has highlighted the promising applications of TAE, TACE, and TARE in extrahepatic cancers such as glioblastoma (GBM), soft tissue sarcomas (STSs), prostate cancer (PCa), pancreatic cancer, and renal cell carcinoma (RCC). This review aims to explore these novel applications, providing a comprehensive summary of the current literature, examining clinical outcomes, and discussing future directions for integrating these techniques into broader oncologic treatment strategies. Methods: A systematic literature review was conducted focusing on LRTs such as TAE, TACE, and TARE in extrahepatic malignancies. Studies published between May 1998 and December 2024 were included, emphasizing outcomes in GBM, STS, PCa, pancreatic cancer, and RCC. Data extraction prioritized clinical outcomes, safety profiles, and procedural efficacy. Results: LRTs demonstrated significant potential in managing extrahepatic malignancies, with TAE, TACE, and TARE showing promising results in palliative management and tumor control. Across studies, these therapies exhibited varying degrees of success in improving progression-free survival and overall survival, with minimal systemic toxicity. Conclusions: The expanding application of LRTs in extrahepatic malignancies highlights their transformative potential in interventional oncology. By offering targeted, minimally invasive treatment options, these modalities bridge critical gaps in managing tumors refractory to conventional therapies. Future research should focus on standardizing protocols, optimizing patient selection, and exploring combination therapies to maximize their clinical efficacy.<\/jats:p>","DOI":"10.3390\/cancers17050726","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:53:06Z","timestamp":1740124386000},"page":"726","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding the Scope of Interventional Oncology: Locoregional Therapies in Extrahepatic Malignancies"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9675-2608","authenticated-orcid":false,"given":"Gavin","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farbod","family":"Fazlollahi","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2498-7132","authenticated-orcid":false,"given":"Mina S.","family":"Makary","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Jipa, A.M., and Makary, M.S. (2024). Locoregional Therapies for Hepatobiliary Tumors: Contemporary Strategies and Novel Applications. Cancers, 16.","DOI":"10.3390\/cancers16071271"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized Controlled Trial of Transarterial Lipiodol Chemoembolization for Unresectable Hepatocellular Carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial Embolisation or Chemoembolisation versus Symptomatic Treatment in Patients with Unresectable Hepatocellular Carcinoma: A Randomised Controlled Trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.gastro.2010.10.049","article-title":"Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared with Chemoembolization in Patients with Hepatocellular Carcinoma","volume":"140","author":"Salem","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-Term Outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jvir.2024.02.017","article-title":"Combination and Optimal Sequencing of Systemic and Locoregional Therapies in Hepatocellular Carcinoma: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel","volume":"35","author":"Thornton","year":"2024","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Bucalau, A.-M., Tancredi, I., and Verset, G. (2021). In the Era of Systemic Therapy for Hepatocellular Carcinoma Is Transarterial Chemoembolization Still a Card to Play?. Cancers, 13.","DOI":"10.3390\/cancers13205129"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jvir.2020.11.011","article-title":"Safety and Efficacy of Arterially Directed Liver Therapies in the Treatment of Hepatic Metastatic Ovarian Cancer: A Retrospective Single-Institution Study","volume":"32","author":"Lacayo","year":"2021","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1245\/s10434-020-09414-5","article-title":"Optimizing the Combination of Immunotherapy and Trans-Arterial Locoregional Therapy for Stages B and C Hepatocellular Cancer","volume":"28","author":"Woeste","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bi, Y., Shi, X., Ren, J., Yi, M., and Han, X. (2022). Transarterial Chemoembolization of Unresectable Renal Cell Carcinoma with Doxorubicin-Loaded CalliSpheres Drug-Eluting Beads. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-12334-x"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.jvir.2017.08.001","article-title":"Transarterial Chemoembolization of Renal Cell Carcinoma: A Prospective Controlled Trial","volume":"28","author":"Karalli","year":"2017","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.clgc.2022.05.006","article-title":"RESIRT: A Phase 1 Study of Selective Internal Radiation Therapy Using Yttrium-90 Resin Microspheres in Patients with Primary Renal Cell Carcinoma","volume":"20","author":"Aslan","year":"2022","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1258\/ar.2012.110413","article-title":"Sequential Combination Treatment (Arterial Embolization and Percutaneous Radiofrequency Ablation) of Inoperable Renal Cell Carcinoma: Single-Center Pilot Study","volume":"53","author":"Nakasone","year":"2012","journal-title":"Acta Radiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00270-004-0090-9","article-title":"Radiofrequency Ablation Combined with Renal Arterial Embolization for the Treatment of Unresectable Renal Cell Carcinoma Larger Than 3.5 Cm: Initial Experience","volume":"29","author":"Yamakado","year":"2006","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1442-2042.2007.01740.x","article-title":"Percutaneous Radiofrequency Ablation with Transarterial Embolization Is Useful for Treatment of Stage 1 Renal Cell Carcinoma with Surgical Risk: Results at 2-year Mean Follow Up","volume":"14","author":"Arima","year":"2007","journal-title":"Int. J. Urol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.yacr.2024.04.004","article-title":"Advancing Radioembolization Through Personalized Dosimetry","volume":"6","author":"Young","year":"2024","journal-title":"Adv. Clin. Radiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1055\/s-0033-1363846","article-title":"Role of Combined Embolization and Ablation in Management of Renal Masses","volume":"31","author":"Winokur","year":"2014","journal-title":"Semin. Interv. Radiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"17588359241280692","DOI":"10.1177\/17588359241280692","article-title":"New Frontiers in Radioembolization","volume":"16","author":"Mansur","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Lu, H., Ye, Q., Zheng, C., Fan, L., and Xia, X. (2023). Efficacy and Safety Analysis of TACE + Sunitinib vs. Sunitinib in the Treatment of Unresectable Advanced Renal Cell Carcinoma: A Retrospective Study. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-10754-0"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00270-019-02227-4","article-title":"Palliative Prostate Artery Embolization for Prostate Cancer: A Case Series","volume":"42","author":"Malling","year":"2019","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.adro.2020.03.015","article-title":"Prostatic Artery Embolization Is Safe and Effective for Medically Recalcitrant Radiation-Induced Prostatitis","volume":"5","author":"Parikh","year":"2020","journal-title":"Adv. Radiat. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jvir.2016.10.010","article-title":"Prostatic Arterial Embolization for Control of Hematuria in Patients with Advanced Prostate Cancer","volume":"28","author":"Chen","year":"2017","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"205846011984606","DOI":"10.1177\/2058460119846061","article-title":"Prostatic Artery Embolization (PAE) for Prostatic Origin Bleeding in the Context of Prostate Malignancy","volume":"8","author":"Tapping","year":"2019","journal-title":"Acta Radiol. Open"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jvir.2020.10.002","article-title":"Early Results of Unilateral Prostatic Artery Embolization as a Focal Therapy in Patients with Prostate Cancer under Active Surveillance: Cancer Prostate Embolisation, a Pilot Study","volume":"32","author":"Frandon","year":"2021","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00270-024-03679-z","article-title":"Prostatic Artery Embolization in Patients with Advanced Prostate Cancer: A Prospective Single Center Pilot Study","volume":"47","author":"Burkhardt","year":"2024","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"480","DOI":"10.21037\/tau-22-189","article-title":"Epirubicin-Loaded Beads Transarterial Prostatic Arterial Chemoembolization Is a Promising Treatment for Advanced Prostate Cancer with Lower Urinary Tract Obstruction or Hematuria\u2014A Case Series Report","volume":"11","author":"Guan","year":"2022","journal-title":"Transl. Androl. Urol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Wang, M. (2021). PAE in the Treatment of Prostate Malignant Tumor. Prostatic Arterial Embolization, Springer.","DOI":"10.1007\/978-981-15-6836-7_10"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jvir.2017.10.013","article-title":"Safety and Efficacy of Prostatic Artery Chemoembolization for Prostate Cancer\u2014Initial Experience","volume":"29","author":"Pisco","year":"2018","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.diii.2021.07.003","article-title":"Prostate Artery Chemoembolization in Prostate Cancer: A Proof of Concept Study in Spontaneous Prostate Cancer in a Canine Model","volume":"102","author":"Pellerin","year":"2021","journal-title":"Diagn. Interv. Imaging"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jvir.2021.01.282","article-title":"Yttrium-90 Radioembolization to the Prostate Gland: Proof of Concept in a Canine Model and Clinical Translation","volume":"32","author":"Mouli","year":"2021","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s002709900246","article-title":"Transacatheter Arterial Embolization for Malignant Osseous and Soft Tissue Sarcomas. II. Clinical Results","volume":"21","author":"Nagata","year":"1998","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/0284185115590435","article-title":"Preoperative Transarterial Embolization Using Gelatin Sponge for Hypervascular Bone and Soft Tissue Tumors in the Pelvis or Extremities","volume":"57","author":"Shimohira","year":"2016","journal-title":"Acta Radiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00432-017-2530-3","article-title":"Drug-Eluting Bead Transarterial Chemoembolization in the Treatment for Unresectable Soft Tissue Sarcoma Refractory to Systemic Chemotherapy: A Preliminary Evaluation of Efficacy and Safety","volume":"144","author":"Ni","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s00270-016-1399-x","article-title":"Treatment Outcome Following Transarterial Chemoembolization in Advanced Bone and Soft Tissue Sarcomas","volume":"39","author":"Jiang","year":"2016","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00270-022-03149-4","article-title":"Transarterial Chemoembolization with Doxorubicin Eluting Beads for Extra-Abdominal Desmoid Tumors: Initial Experience","volume":"45","author":"Kim","year":"2022","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Elnekave, E., Ben Ami, E., Shamai, S., Peretz, I., Tamir, S., Bruckheimer, E., Stemmer, A., Erinjeri, J., Abu Quider, A., and Seidensticker, M. (2022). Selective Intra-Arterial Doxorubicin Eluting Microsphere Embolization for Desmoid Fibromatosis: A Combined Prospective and Retrospective Study. Cancers, 14.","DOI":"10.3390\/cancers14205045"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.jvir.2024.06.034","article-title":"Embolization of the Pancreas Using Microspheres: A Proof-of-Safety Study in a Porcine Model","volume":"35","author":"Cline","year":"2024","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Cao, Y., Yu, D., Wu, Y., and Zhu, W. (2024). Regional Intra-Arterial vs. Systemic Chemotherapy for the Treatment of Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1197424"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Huang, C., Cheng, C., Shen, Y., Chen, H., Lin, J., Hua, Y., Feng, L., Wu, C., Wang, P., and Chen, Z. (2024). Digital Subtraction Angiography-Guided Pancreatic Arterial Infusion of GEMOX Chemotherapy in Advanced Pancreatic Adenocarcinoma: A Phase II, Open-Label, Randomized Controlled Trial Comparing with Intravenous Chemotherapy. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12695-8"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2214\/AJR.11.8008","article-title":"Unresectable Pancreatic Cancer: Arterial Embolization to Achieve a Single Blood Supply for Intraarterial Infusion of 5-Fluorouracil and Full-Dose IV Gemcitabine","volume":"198","author":"Tanaka","year":"2012","journal-title":"Am. J. Roentgenol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/oncolo\/oyae178","article-title":"Treatment of Locally Advanced Pancreatic Cancer Using Localized Trans-Arterial Micro Perfusion of Gemcitabine: Combined Analysis of RR1 and RR2","volume":"29","author":"Hatoum","year":"2024","journal-title":"Oncologist"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13550-020-00679-1","article-title":"Yttrium-90 Radioembolization as a Possible New Treatment for Brain Cancer: Proof of Concept and Safety Analysis in a Canine Model","volume":"10","author":"Pasciak","year":"2020","journal-title":"EJNMMI Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"iii37","DOI":"10.1093\/noajnl\/vdad070.147","article-title":"Tips-17 a First-in-Human Feasibility Study to Evaluate the Safety of Selective Intra-Arterial Yttrium-90 Microsphere Treatment in Patients with Recurrent Glioblastoma (The Frontier Trial)","volume":"5","author":"Mouli","year":"2023","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11060-021-03851-2","article-title":"Repeated Superselective Intraarterial Bevacizumab after Blood Brain Barrier Disruption for Newly Diagnosed Glioblastoma: A Phase I\/II Clinical Trial","volume":"155","author":"Patel","year":"2021","journal-title":"J. Neurooncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3171\/2021.3.PEDS20738","article-title":"Intraarterial Delivery of Bevacizumab and Cetuximab Utilizing Blood-Brain Barrier Disruption in Children with High-Grade Glioma and Diffuse Intrinsic Pontine Glioma: Results of a Phase I Trial","volume":"28","author":"McCrea","year":"2021","journal-title":"J. Neurosurg. Pediatr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11060-016-2099-8","article-title":"Superselective Intraarterial Cerebral Infusion of Cetuximab after Osmotic Blood\/Brain Barrier Disruption for Recurrent Malignant Glioma: Phase I Study","volume":"128","author":"Chakraborty","year":"2016","journal-title":"J. Neurooncol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Kappel, A.D., Jha, R., Guggilapu, S., Smith, W.J., Feroze, A.H., Dmytriw, A.A., Vicenty-Padilla, J., Alcedo Guardia, R.E., Gessler, F.A., and Patel, N.J. (2024). Endovascular Applications for the Management of High-Grade Gliomas in the Modern Era. Cancers, 16.","DOI":"10.3390\/cancers16081594"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.14740\/wjon1279","article-title":"Epidemiology of Renal Cell Carcinoma","volume":"11","author":"Padala","year":"2020","journal-title":"World J. Oncol."},{"key":"ref_50","unstructured":"Garfield, K., and LaGrange, C.A. (2024). Renal Cell Cancer (Archived). StatPearls, StatPearls Publishing."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer Statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Wu, G., Bajestani, N., and Makary, M.S. (2024). Locoregional Therapy Approaches for Renal Cell Carcinoma: Current Strategies and Future Directions. Interdisciplinary Cancer Research, Springer International Publishing.","DOI":"10.1007\/16833_2024_473"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3322\/caac.21411","article-title":"Treatment of Renal Cell Carcinoma: Current Status and Future Directions","volume":"67","author":"Barata","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","article-title":"European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update","volume":"82","author":"Ljungberg","year":"2022","journal-title":"Eur. Urol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1007\/s00261-022-03502-8","article-title":"Trans-Arterial Embolization of Renal Cell Carcinoma: A Systematic Review and Meta-Analysis","volume":"47","author":"Wright","year":"2022","journal-title":"Abdom. Radiol."},{"key":"ref_56","unstructured":"Pandey, J., and Syed, W. (2024). Renal Cancer. StatPearls, StatPearls Publishing."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal Cell Carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Primer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/JU.0000000000001911","article-title":"Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I","volume":"206","author":"Campbell","year":"2021","journal-title":"J. Urol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Campbell, W.A., and Makary, M.S. (2024). Advances in Image-Guided Ablation Therapies for Solid Tumors. Cancers, 16.","DOI":"10.3390\/cancers16142560"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.3748\/wjg.v21.i27.8271","article-title":"Effects of Yttrium-90 Selective Internal Radiation Therapy on Non-Conventional Liver Tumors","volume":"21","author":"Kuei","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jvir.2012.10.027","article-title":"Radioembolization of Renal Cell Carcinoma Using Yttrium-90 Microspheres","volume":"24","author":"Hamoui","year":"2013","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/RLU.0000000000005209","article-title":"Ablative Radioembolization (SIRT) of a Large Inoperable Renal Cell Carcinoma Invading the Liver That Resulted in Hematuria Control and Complete Necrosis by mRECIST Criteria","volume":"49","author":"Spyridonidis","year":"2024","journal-title":"Clin. Nucl. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11934-018-0827-7","article-title":"Role of Angio-Embolization for Renal Cell Carcinoma","volume":"19","author":"Gunn","year":"2018","journal-title":"Curr. Urol. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1055\/s-0040-1715884","article-title":"Renal Artery Embolization for Neoplastic Conditions","volume":"37","author":"Lionberg","year":"2020","journal-title":"Semin. Interv. Radiol."},{"key":"ref_65","unstructured":"Leslie, S.W., Soon-Sutton, T.L., and Skelton, W.P. (2024). Prostate Cancer. StatPearls, StatPearls Publishing."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","article-title":"Prostate Cancer, Version 3.2024: Featured Updates to the NCCN Guidelines","volume":"22","author":"Schaeffer","year":"2024","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jvir.2018.01.766","article-title":"Prostatic Artery Embolization in the Treatment of Localized Prostate Cancer: A Bicentric Prospective Proof-of-Concept Study of 12 Patients","volume":"29","author":"Mordasini","year":"2018","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Moramarco, L., Grande, A.M., Vertemati, M., and Aseni, P. (2023). Prostate Artery Embolization in the Treatment of Massive Intractable Bleeding from Prostatic Neoplasms: A Case Report and Systematic Review. J. Clin. Med., 13.","DOI":"10.20944\/preprints202311.1382.v1"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.euf.2023.02.005","article-title":"Prostatic Artery Embolization in Patients with Prostate Cancer: A Systematic Review","volume":"10","author":"Burkhardt","year":"2024","journal-title":"Eur. Urol. Focus"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00270-024-03759-0","article-title":"What Role Does PAE Play in the Management of Prostate Cancer?","volume":"47","author":"Mouli","year":"2024","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_71","unstructured":"(2024). First in Human Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device (VOYAGER), Boston Scientific Corporation."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"815","DOI":"10.6004\/jnccn.2022.0035","article-title":"Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Kane","year":"2022","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Shu, C., Lim, M., and Fang, A. (2023). Transarterial Embolization and Percutaneous Ablation of Primary and Metastatic Soft Tissue Tumors. Life, 13.","DOI":"10.3390\/life13071485"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1159\/000520381","article-title":"A Successful Chemoembolization of a Retroperitoneal Soft Tissue Sarcoma: A Case Report","volume":"14","author":"Uchiyama","year":"2021","journal-title":"Case Rep. Oncol."},{"key":"ref_75","unstructured":"Puckett, Y., and Garfield, K. (2024). Pancreatic Cancer. StatPearls, StatPearls Publishing."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Bugazia, D., Al-Najjar, E., Esmail, A., Abdelrahim, S., Abboud, K., Abdelrahim, A., Umoru, G., Rayyan, H.A., Abudayyeh, A., and Al Moustafa, A.-E. (2024). Pancreatic Ductal Adenocarcinoma: The Latest on Diagnosis, Molecular Profiling, and Systemic Treatments. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1386699"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/1097-0142(20000715)89:2<303::AID-CNCR15>3.0.CO;2-1","article-title":"A Novel Arterial Infusion Chemotherapy for the Treatment of Patients with Advanced Pancreatic Carcinoma after Vascular Supply Distribution via Superselective Embolization","volume":"89","author":"Homma","year":"2000","journal-title":"Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.4251\/wjgo.v13.i12.2064","article-title":"Current Status of Non-Surgical Treatment of Locally Advanced Pancreatic Cancer","volume":"13","author":"Spiliopoulos","year":"2021","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"TPS773","DOI":"10.1200\/JCO.2023.41.4_suppl.TPS773","article-title":"Targeted Intra-Arterial Gemcitabine vs. Continuation of IV Gemcitabine plus Nab-Paclitaxel Following Induction with Sequential IV Gemcitabine plus Nab-Paclitaxel and Radiotherapy for Unresectable Locally Advanced Pancreatic Cancer (TIGeR-PaC): A Randomized Phase 3 Multicenter Study","volume":"41","author":"Pishvaian","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_80","unstructured":"Kanderi, T., Munakomi, S., and Gupta, V. (2024). Glioblastoma Multiforme. StatPearls, StatPearls Publishing."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Cruz, N., Herculano-Carvalho, M., Roque, D., Faria, C.C., Casc\u00e3o, R., Ferreira, H.A., Reis, C.P., and Matela, N. (2023). Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15030928"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.semcancer.2018.09.007","article-title":"Cellular and Molecular Mechanisms of Glioblastoma Malignancy: Implications in Resistance and Therapeutic Strategies","volume":"58","author":"Matias","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Rabah, N., Ait Mohand, F.-E., and Kravchenko-Balasha, N. (2023). Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241814256"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Pinkiewicz, M., Pinkiewicz, M., Walecki, J., and Zawadzki, M. (2022). A Systematic Review on Intra-Arterial Cerebral Infusions of Chemotherapeutics in the Treatment of Glioblastoma Multiforme: The State-of-the-Art. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.950167"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jocn.2015.10.019","article-title":"Endovascular Therapies for Malignant Gliomas: Challenges and the Future","volume":"26","author":"Su","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00270-022-03270-4","article-title":"Overview of Ongoing Clinical Trials on Radioembolization","volume":"45","author":"Fabritius","year":"2022","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1016\/S1470-2045(24)00145-1","article-title":"Translating the Theranostic Concept to Neuro-Oncology: Disrupting Barriers","volume":"25","author":"Albert","year":"2024","journal-title":"Lancet Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Hoggarth, A.R., Muthukumar, S., Thomas, S.M., Crowley, J., Kiser, J., and Witcher, M.R. (2024). Clinical Theranostics in Recurrent Gliomas: A Review. Cancers, 16.","DOI":"10.3390\/cancers16091715"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s00270-022-03228-6","article-title":"SIRT in 2025","volume":"45","author":"Ponziani","year":"2022","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11060-024-04782-4","article-title":"Endovascular Surgical Neuro-Oncology: Advancing a New Subspecialty","volume":"170","author":"Young","year":"2024","journal-title":"J. Neurooncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3109\/02688697.2013.877122","article-title":"The Role of Intra-Arterial Chemotherapy as an Adjuvant Treatment for Glioblastoma","volume":"28","author":"Theodotou","year":"2014","journal-title":"Br. J. Neurosurg."},{"key":"ref_92","first-page":"145","article-title":"Superselective Intraarterial Cerebral Infusion of Bevacizumab: A Revival of Interventional Neuro-Oncology for Malignant Glioma","volume":"8","author":"Riina","year":"2009","journal-title":"J. Exp. Ther. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4103\/ua.ua_114_23","article-title":"Survival Rate Comparisons of Angioembolization and Neoadjuvant Targeted Therapy on Unresectable Renal Cell Carcinoma Patients: A Systematic Review","volume":"16","author":"Muhammad","year":"2024","journal-title":"Urol. Ann."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.4103\/jcrt.jcrt_1310_21","article-title":"Clinical Observation of Local Intervention Combined with Camrelizumab and Apatinib in the Treatment of Metastatic Soft-Tissue Sarcoma","volume":"17","author":"Li","year":"2021","journal-title":"J. Cancer Res. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00270-011-0130-1","article-title":"Is Embolization of the Pancreas Safe? Pancreatic Histological Changes after Selective Transcatheter Arterial Embolization with N-Butyl Cyanoacrylate in a Swine Model","volume":"35","author":"Okada","year":"2012","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"314.e9","DOI":"10.1016\/j.crad.2020.11.111","article-title":"Safety and Efficacy of Transarterial Embolisation for Treatment of Dorsal Pancreatic Artery Haemorrhage","volume":"76","author":"Alhazemi","year":"2021","journal-title":"Clin. Radiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/cncr.31219","article-title":"Phase 1\/2 Trial of Temsirolimus and Sorafenib in the Treatment of Patients with Recurrent Glioblastoma: North Central Cancer Treatment Group Study\/Alliance N0572","volume":"124","author":"Schiff","year":"2018","journal-title":"Cancer"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/5\/726\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:39:21Z","timestamp":1760027961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/5\/726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":97,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["cancers17050726"],"URL":"https:\/\/doi.org\/10.3390\/cancers17050726","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2025,2,21]]}}}